- £216.82bn
- £234.96bn
- $54.07bn
- 78
- 15
- 98
- 73
REG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Divestment of hypertension medicines completed
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - AstraZeneca divests global rights to Movantik
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - Calisen Group Hldgs - Expected Intention to Float Announcement
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - AZN: Full-year and Q4 2019 results
AnnouncementREG - JPMorgan Elect PLC JPMorgan Elect-JPEI JPMorgan Elect PLC . - Ten Largest Investments
AnnouncementREG - Law Debenture Corp - Net Asset Value and Portfolio Update
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - AstraZeneca divests hypertension medicines
AnnouncementREG - AstraZeneca PLC - Brilinta met primary endpoint in stroke trial
AnnouncementREG - AstraZeneca PLC - Enhertu Phase II trial met primary endpoint
AnnouncementREG - AstraZeneca PLC - AstraZeneca to recover brazikumab (MEDI2070)
AnnouncementREG - AstraZeneca PLC - FDA grants Lynparza Priority Review for PROfound
AnnouncementREG - AstraZeneca PLC - Imfinzi, tremelimumab granted ODD in liver cancer
Announcement